Avid Bioservices Inc (CDMO)

[pphmtoolong]

Carboat, your brutally pessimistic view of Peregrine has turned out to be too accurate. Good on you.

However, your typically pessimistic view on Avid ignores the growing capacity, growing client list and backlog of confirmed orders.

Avid now has the capacity to generate $80 million gross annual income. Remember the confirmed backlog is already $59 million.

The Sunrise flop has forced Peregrine to cut back Bavi development for an uncertain period. When it re-starts, I expect the expenses will be modest at first.

So, reduced development expenses are very probable. Revenue increase is very probable.

Will Peregrine turn profitable in the next year? Maybe so. If it does, I'm sure you will praise Peregrine management and turn from a brutal critic to a fervent cheer leader.

GLTA, Paul